Source: Eur Respir J, 52 (3) 1702616; 10.1183/13993003.02616-2017
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Winfried Randerath, Claudio L. Bassetti, Maria R. Bonsignore, Ramon Farre, Luigi Ferini-Strambi, Ludger Grote, Jan Hedner, Malcolm Kohler, Miguel-Angel Martinez-Garcia, Stefan Mihaicuta, Josep Montserrat, Jean-Louis Pepin, Dirk Pevernagie, Fabio Pizza, Olli Polo, Renata Riha, Silke Ryan, Johan Verbraecken, Walter T. McNicholas. Challenges and perspectives in obstructive sleep apnoea. Eur Respir J, 52 (3) 1702616; 10.1183/13993003.02616-2017

Member's Comments

No comment yet.

Related content which might interest you: Ato-oxy as the first successful pharmacotherapy for obstructive sleep apnoea Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside Year: 2019 Screening for obstructive sleep apnoea in professional drivers Source: Breathe, 16 (1) 29364; 10.1183/20734735.0364-2019 Year: 2020 Clinical assessment of obstructive sleep apnoea Source: Annual Congress 2009 - PG5 Core Curriculum Postgraduate Course: Obstructive sleep apnoea – current pathophysiological, clinical and therapeutic concepts Year: 2009 From the laboratory to the bedside: the pharmacotherapy of obstructive sleep apnoea Source: Sleep and Breathing Conference 2021 Year: 2021 Recommendations for the management of patients with obstructive sleep apnoea and hypertension Source: Guidelines 2013 Year: 2013 Advances in the surgical treatment of obstructive sleep apnoea Source: International Congress 2017 – Multidisciplinary management of sleep apnoea Year: 2017 Surgical approaches to the treatment of obstructive sleep apnea Source: Virtual Congress 2020 – New technologies for the management of COPD and obstructive sleep apnea and the diagnosis of lung cancer Year: 2020 Telemedicine(TM)-based strategy for management of obstructive sleep apnea (OSA): Virtual sleep unit Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options Year: 2018 The velumount device for obstructive sleep apnoea Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Clinical assessment of obstructive sleep apnoea Source: Annual Congress 2006 - PG9 - Obstructive sleep apnoea: current pathophysiological, clinical and therapeutic concepts Year: 2006 Non-CPAP therapies in obstructive sleep apnoea Source: Guideline 2011 Year: 2011 Pathophysiological consequences of obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Pulmonary hypertension and obstructive sleep apnea syndrome -Marmara Universitypediatric sleep laboratory experience Source: Virtual Congress 2020 – Respiratory physiology and sleep: what is new? Year: 2020 The puzzle of metabolic effects of obstructive sleep apnoea in children Source: Eur Respir J 2016; 47: 1050-1053 Year: 2016 Prevalence of complex sleep apnea among German patients with obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Improving adherence to treatment in patients with obstructive sleep apnoea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 The metabolic consequences of obstructive sleep apnoea in children Source: Breathe 2009; 6: 111-114 Year: 2009 Diagnosis of obstructive sleep apnoea in children: standards for sleep study duration Source: International Congress 2019 – New developments in sleep-disordered breathing, gas exchange and lung function in children Year: 2019 Treating obstructive sleep apnoea to improve control of hypertension Source: International Congress 2014 – ERS/JAMA lunchtime session: 2014 highlights Year: 2014